A group of scientists, public health experts, and policy researchers responded to the preliminary draft recommendations from the National Science Advisory Board on Biosecurity (NSABB) regarding the US government’s policy for oversight of research involving enhanced potential pandemic pathogens (ePPP) and life sciences dual-use research of concern (DURC).